Literature DB >> 10982786

Two independent mechanisms down-regulate the intrinsic SecA ATPase activity.

H Nakatogawa1, H Mori, K Ito.   

Abstract

SecA initiates protein translocation by interacting with ATP, preprotein, and the SecYEG membrane components. Under such conditions, it undergoes a conformational change characterized as membrane insertion, which is then followed by hydrolysis of ATP, enabling the release of the preprotein and deinsertion of SecA itself for the next cycle of reactions. Without ongoing translocation, the ATPase activity of SecA is kept very low. Previously, it was shown that the C-terminal 34-kDa domain of SecA interacts with the N-terminal 68-kDa ATPase domain to down-regulate the ATPase. Here, we show, using a deregulated SecA mutant, that the intrinsic ATPase activity is subject to dual inhibitory mechanisms. Thus, the proposed second ATP-binding domain down-regulates the ATPase activity executed by the primary ATPase domain. This regulation, within the N-terminal ATPase domain, operates independently of the C-terminal domain-mediated regulation. The absence of both the mechanisms resulted in a 50-fold elevation of translocation-uncoupled ATP hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982786     DOI: 10.1074/jbc.C000550200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  An essential amino acid residue in the protein translocation channel revealed by targeted random mutagenesis of SecY.

Authors:  H Mori; K Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Cross-talk between catalytic and regulatory elements in a DEAD motor domain is essential for SecA function.

Authors:  G Sianidis; S Karamanou; E Vrontou; K Boulias; K Repanas; N Kyrpides; A S Politou; A Economou
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

3.  Biochemical characterization of a mutationally altered protein translocase: proton motive force stimulation of the initiation phase of translocation.

Authors:  Hiroyuki Mori; Koreaki Ito
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

4.  SecM facilitates translocase function of SecA by localizing its biosynthesis.

Authors:  Hitoshi Nakatogawa; Akiko Murakami; Hiroyuki Mori; Koreaki Ito
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

5.  Different modes of SecY-SecA interactions revealed by site-directed in vivo photo-cross-linking.

Authors:  Hiroyuki Mori; Koreaki Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

6.  Additional in vitro and in vivo evidence for SecA functioning as dimers in the membrane: dissociation into monomers is not essential for protein translocation in Escherichia coli.

Authors:  Hongyun Wang; Bing Na; Hsiuchin Yang; Phang C Tai
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

7.  Mechanisms of Rose Bengal inhibition on SecA ATPase and ion channel activities.

Authors:  Ying-Hsin Hsieh; Ying-Ju Huang; Jin-Shan Jin; Liyan Yu; Hsiuchin Yang; Chun Jiang; Binghe Wang; Phang C Tai
Journal:  Biochem Biophys Res Commun       Date:  2014-10-19       Impact factor: 3.575

8.  Characterization of the minimal length of functional SecA in Escherichia coli.

Authors:  Bing Na; Zhipeng You; Hsiuchin Yang; Phang C Tai
Journal:  Biochem Biophys Res Commun       Date:  2014-11-22       Impact factor: 3.575

9.  A SecE mutation that modulates SecY-SecE translocase assembly, identified as a specific suppressor of SecY defects.

Authors:  Hiroyuki Mori; Yoshinori Akiyama; Koreaki Ito
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

10.  Phospholipids induce conformational changes of SecA to form membrane-specific domains: AFM structures and implication on protein-conducting channels.

Authors:  Zhipeng You; Meijiang Liao; Hao Zhang; Hsiuchin Yang; Xijian Pan; John E Houghton; Sen-Fang Sui; Phang C Tai
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.